References
Alderazi YJ, Coons SW, Chapman K (2012) Catastrophic demyelinating encephalomyelitis after intrathecal and intravenous stem cell transplantation in a patient with multiple sclerosis. J Child Neurol. https://doi.org/10.1177/0883073811422831
Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L et al (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. https://doi.org/10.1371/journal.pmed.1000029
Bauer G, Elsallab M, Abou-El-Enein M (2018) Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Med Stem Cells Transl. https://doi.org/10.1002/sctm.17-0282
Berkowitz AL, Miller MB, Mir SA, Cagney D, Chavakula V, Guleria I et al (2016) Glioproliferative lesion of the spinal cord as a complication of stem-cell tourism. N Engl J Med. https://doi.org/10.1056/NEJMc1600188
Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ et al (2012) Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. https://doi.org/10.3389/fimmu.2012.00297
Hurst RW, Peter Bosch E, Morris JM, Dyck PJB, Reeves RK (2013) Inflammatory hypertrophic cauda equina following intrathecal neural stem cell injection. Muscle Nerve. https://doi.org/10.1002/mus.23920
Julian K, Yuhasz N, Hollingsworth E, Imitola J (2018) The growing reality of the neurological complications of global stem cell tourism. Semin Neurol. https://doi.org/10.1055/s-0038-1649338
Kline CN, Joseph NM, Grenert JP, Van Ziffle J, Talevich E, Onodera C et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. https://doi.org/10.1093/neuonc/now254
Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE et al (2017) Vision loss after intravitreal injection of autologous “Stem Cells” for AMD. N Engl J Med. https://doi.org/10.1056/NEJMoa1609583
Lee BS, Achey RL, Yeaney GA, Bosler DS, Aly Z, Ontaneda D et al (2018) Stem cell injection-induced glioneuronal lesion of the cauda equina. Neurology. https://doi.org/10.1212/WNL.0000000000005219
Ney D, Fridman V, Ewalt M, Kleinschmidt-DeMasters BK (2018) RARE-27. Chimeric spinal cord glioproliferative lesion following intrathecal fetal stem cell infusion. Neuro Oncol. https://doi.org/10.1093/neuonc/noy148.1000 (Abstract only)
Qu S, Liu W, Yang H, Wang Z, Yang Y, Liu F et al (2017) Analysis of adverse events related to 720 cases of neural progenitor cell transplantation. CNS Neurol Disord Drug Targets. https://doi.org/10.2174/1871527315666161207160258
Rahangdale R, Rana S, Prakash P, Ali M, Flaherty M, Synowiec A et al (2019) Glioneuronal growth infiltrating lumbosacral nerve roots following intrathecal stem cell injections highlighting perils of stem cell tourism. Mov Disord Clin Pract. https://doi.org/10.1002/mdc3.12741
Thirabanjasak D, Tantiwongse K, Thorner PS (2010) Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2009111156
Turner L, Knoepfler P (2016) Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. https://doi.org/10.1016/j.stem.2016.06.007
Wilson MR, O’Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP et al (2018) Chronic meningitis investigated via metagenomic next-generation sequencing. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2018.0463
Acknowledgements
The authors wish to thank the patient, who gave informed consent for publication of this study, for his invaluable contributions to neuroscience research. The authors also wish to thank Dr. Arie Perry for thoughtful discussions during initial work-up of the patient’s biopsy, and clinic nurse Denise Feng, RN, for her assistance and follow-up care of the patient. This work was supported by the Sandler and William K. Bowes Jr Foundations, a National Institute of Neurological Disorders and Stroke award (K08NS096117); and an American Academy of Neurology Clinical Research Training Scholarship (P0534134).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
ARK is a co-founder and member of the board of Neurona Therapeutics. Other authors have no conflicts of interest relevant to this article.
Informed consent
Informed consent was obtained from the individual participant described in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
401_2019_2089_MOESM1_ESM.tif
Supplementary Figure S1. Additional radiologic evaluation of progressive S1 nerve root thickening. a-b Sagittal serial MR images obtained approximately 16 months apart show progressive diffuse thickening of all the cauda equina nerve roots with effacement of the CSF space (arrows). c-d Positron emission computed topography (PET-CT) imaging shows increased uptake in the lumbosacral spinal cord, cauda equina, and associated nerve roots. (TIFF 4187 kb)
401_2019_2089_MOESM2_ESM.tif
Supplementary Figure S2. Additional characterization of aberrant neuroglial tissue. a H&E section demonstrating nerve root (lower left) encased by aberrant neuroglial tissue; mitoses were not identified. The glial component shows diffuse positivity for ATRX (b) and scattered positivity for OLIG2 (c). d The Ki-67 labeling index is less than 1%. Scale bar = 50 µm for all panels. (TIFF 9122 kb)
401_2019_2089_MOESM3_ESM.tif
Supplementary Figure S3. Immunohistochemical characterization of the inflammatory infiltrate in aberrant neuroglial tissue. a H&E sections from deeper within the tissue block showed scattered and clustered small inflammatory cells. b The vast majority of inflammatory cells are T lymphocytes, as identified by CD3 immunoreactivity. c B lymphocytes were essentially absent, as demonstrated by immunohistochemistry for CD20. d CD68 highlights scattered macrophages and microglia within the neuroglial tissue. Scale bar = 50 µm for all panels. (TIFF 9123 kb)
Rights and permissions
About this article
Cite this article
Sloan, E.A., Sampognaro, P.J., Junn, J.C. et al. Neuroglial stem cell-derived inflammatory pseudotumor (n-SCIPT): clinicopathologic characterization of a novel lesion of the lumbosacral spinal cord and nerve roots following intrathecal allogeneic stem cell intervention. Acta Neuropathol 138, 1103–1106 (2019). https://doi.org/10.1007/s00401-019-02089-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-019-02089-7